Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma

Molecular Therapy

Volumn 18, Issue 10, 2010, Pages 1885-1890

  Ildefonso, Cristhian J ^a   Kong, Lingkun ^a   Leen, Ann ^a,b   Chai, Samantha J ^a   Petrochelli, Veronica ^c   Chintagumpala, Murali ^a,c,d   Hurwitz, Mary Y ^a,b   Chévez Barrios, Patricia ^a,c,d   Hurwitz, Richard L ^a,b,c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d Retinoblastoma Center of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; NEUTRALIZING ANTIBODY; THYMIDINE KINASE;

ANTIGEN PRESENTING CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENUCLEATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; PHASE 1 CLINICAL TRIAL; PLASMA CELL; RETINOBLASTOMA; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

EID: 77957587385     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.139     Document Type: Article

References (34)

1. Christ, M, Lusky, M, Stoeckel, F, Dreyer, D, Dieterlé, A, Michou, AI et al. (1997). Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol Lett 57: 19-25.
2. Muruve, DA (2004). The innate immune response to adenovirus vectors. Hum Gene Ther 15: 1157-1166.
3. Franklin, RM and Prendergast, RA (1970). Primary rejection of skin allografts in the anterior chamber of the rabbit eye. J Immunol 104: 463-469.
4. Kaplan, HJ and Streilein, JW (1977). Analysis of immunologic privilege within the anterior chamber of the eye. Transplant Proc 9: 1193-1195.
5. Raju, S, Grogan, JB and Hardy, JD (1969). A new test of rejection for implants in the anterior chamber of the eye: application for the study of immunological mechanisms operative in a privileged site. Am Surg 35: 856-863.
6. Taylor, AW (2009). Ocular immune privilege. Eye (Lond) 23: 1885-1889.
7. Suber, ML, Hurwitz, MY, Chévez-Barrios, P and Hurwitz, RL (2001). Immune consequences of intraocular administration of modified adenoviral vectors. Hum Gene Ther 12: 833-838.
8. Mallam, JN, Hurwitz, MY, Mahoney, T, Chévez-Barrios, P and Hurwitz, RL (2004). Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression. Invest Ophthalmol Vis Sci 45: 1680-1687.
9. van der Linden, RR, Haagmans, BL, Mongiat-Artus, P, van Doornum, GJ, Kraaij, R, Kadmon, D et al. (2005). Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur Urol 48: 153-161.
10. Abramson, DH, Frank, CM, Chantada, GL, de Totah, AB, de Pifano, IT, Ramírez, GT et al. (1999). Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma. Ophthalmic Genet 20: 31-36.
11. Cunha-Vaz, JG (1976). The blood-retinal barriers. Doc Ophthalmol 41: 287-327.
12. Chévez-Barrios, P, Chintagumpala, M, Mieler, W, Paysse, E, Boniuk, M, Kozinetz, C et al. (2005). Response of retinoblastoma with vitreous tumor seeding to adenovirusmediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol 23: 7927-7935.
13. Leen, AM, Sili, U, Vanin, EF, Jewell, AM, Xie, W, Vignali, D et al. (2004). Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104: 2432-2440.
14. Leen, AM, Myers, GD, Sili, U, Huls, MH, Weiss, H, Leung, KS et al. (2006). Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 12: 1160-1166.
15. Ohrmalm, L, Lindblom, A, Omar, H, Norbeck, O, Gustafson, I, Lewensohn-Fuchs, I et al. (2010). Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant (epub ahead of print).
16. Myers, GD, Bollard, CM, Wu, MF, Weiss, H, Rooney, CM, Heslop, HE et al. (2007). Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 39: 677-686.
17. Olive, M, Eisenlohr, L, Flomenberg, N, Hsu, S and Flomenberg, P (2002). The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther 13: 1167-1178.
18. Smythe, WR, Hwang, HC, Amin, KM, Eck, SL, Davidson, BL, Wilson, JM et al. (1994). Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 54: 2055-2059.
19. Maguire, AM, Simonelli, F, Pierce, EA, Pugh, EN Jr, Mingozzi, F, Bennicelli, J et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248.
20. Hoffman, LM, Maguire, AM and Bennett, J (1997). Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 38: 2224-2233.
21. Anand, V, Duffy, B, Yang, Z, Dejneka, NS, Maguire, AM and Bennett, J (2002). A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol Ther 5: 125-132.
22. Hurwitz, RL, Shields, CL, Shields, JA, Chevez-Barrios, P, Hurwitz, MY and Chintagumpala, M (2002). Retinoblastoma. In: Pizzo, PA and Poplack, DG (eds). Principles and Practice of Pediatric Oncology. Lippincott-Raven: Philadelphia, PA. pp. 825-846.
23. Hurwitz, RL, Chévez-Barrios, P, Boniuk, M, Chintagumpala, M and Hurwitz, MY (2003). Retinoblastoma: from bench to bedside. Expert Rev Mol Med 5: 1-14.
24. Xu, F, Li, S, Li, XL, Guo, Y, Zou, BY, Xu, R et al. (2009). Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors. Cancer Gene Ther 16: 723-730.
25. Camelo, S, Kezic, J and McMenamin, PG (2005). Anterior chamber-associated immune deviation: a review of the anatomical evidence for the afferent arm of this unusual experimental model of ocular immune responses. Clin Experiment Ophthalmol 33: 426-432.
26. Streilein, JW, Wilbanks, GA and Cousins, SW (1992). Immunoregulatory mechanisms of the eye. J Neuroimmunol 39: 185-200.
27. Streilein, JW (2003). Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3: 879-889.
28. Saban, DR, Cornelius, J, Masli, S, Schwartzkopff, J, Doyle, M, Chauhan, SK et al. (2008). The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens. Mol Vis 14: 2435-2442.
29. Raper, SE, Chirmule, N, Lee, FS, Wivel, NA, Bagg, A, Gao, GP et al. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158.
30. Bowen, GP, Borgland, SL, Lam, M, Libermann, TA, Wong, NC and Muruve, DA (2002). Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther 13: 367-379.
31. Molinier-Frenkel, V, Gahery-Segard, H, Mehtali, M, Le Boulaire, C, Ribault, S, Boulanger, P et al. (2000). Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol 74: 7678-7682.
32. Michou, AI, Santoro, L, Christ, M, Julliard, V, Pavirani, A and Mehtali, M (1997). Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther 4: 473-482.
33. Byrnes, AP, MacLaren, RE and Charlton, HM (1996). Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J Neurosci 16: 3045-3055.
34. Brenner, MK (2010). The eyes have it. Mol Ther 18: 451-452.